What is F5's earnings per share (EPS)?

F5 (FFIV) reported diluted earnings per share of $11.80 for fiscal year 2025. This represents a 23.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

F5 Financials

FFIV

Trailing 12 months to June 30, 2026

Revenue $3.3B +9.4% YoY

Net Income $726.5M +8.9% YoY

EPS (Diluted) $12.56 +10.7% YoY

Free Cash Flow $969.6M +1.5% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE September

F5 (FFIV) reported $3.3B in revenue over the twelve months to Jun 30, 2026, up 9.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI FFIV FY2025 2026-08-29

F5 is turning moderate sales growth into disproportionate profit and cash expansion through operating leverage and modest reinvestment.

The company grew revenue while operating margin expanded from 16.8% to 24.8%, revealing operating leverage rather than sales volume alone. That improvement reached cash: FY2025 free cash flow was $906M versus $692M of net income, tying the earnings increase to cash generation rather than merely accounting presentation.

Gross margin widened from 80.2% to 81.4%, showing slightly better underlying economics before overhead. Net margin rose from 20.1% to 22.4%, so the improvement persisted through the full income statement.

FY2025 share buybacks were $502M, yet equity increased to $3.6B, indicating internally generated profits more than replenished shareholder distributions. The current ratio reached 1.6x from 1.0x in FY2022, meaning working-capital headroom improved while capital continued to be returned.

Financial Health Signals

Financial Health Score 68/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of F5's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

F5 has an operating margin of 24.8%, meaning the company retains $25 of operating profit per $100 of revenue. This strong profitability earns a score of 86/100, reflecting efficient cost management and pricing power. This is up from 23.4% the prior year.

Growth

F5's revenue grew 9.7% year-over-year to $3.1B, a solid pace of expansion. This earns a growth score of 49/100.

Leverage

F5 has a moderate D/E ratio of 0.76. This balance of debt and equity financing earns a leverage score of 52/100.

Liquidity

F5's current ratio of 1.56 indicates adequate short-term liquidity, earning a score of 43/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

F5 converts 29.3% of revenue into free cash flow ($906.4M). This strong cash generation earns a score of 93/100.

Returns

F5 earns a strong 19.3% return on equity (ROE), meaning it generates $19 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 84/100. This is up from 18.1% the prior year.

Altman Z-Score Safe

6.76

F5 scores 6.76, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($22.3B) relative to total liabilities ($2.7B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

7/8

F5 passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.37x

For every $1 of reported earnings, F5 generates $1.37 in operating cash flow ($949.7M OCF vs $692.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.1B

YoY+9.7%

5Y CAGR+5.6%

10Y CAGR+4.9%

F5 generated $3.1B in revenue in fiscal year 2025. This represents an increase of 9.7% from the prior year.

EBITDA

$858.3M

YoY+12.1%

5Y CAGR+12.0%

10Y CAGR+3.6%

F5's EBITDA was $858.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 12.1% from the prior year.

Net Income

$692.4M

YoY+22.2%

5Y CAGR+17.6%

10Y CAGR+6.6%

F5 reported $692.4M in net income in fiscal year 2025. This represents an increase of 22.2% from the prior year.

EPS (Diluted)

$11.80

YoY+23.6%

5Y CAGR+18.7%

10Y CAGR+8.9%

F5 earned $11.80 per diluted share (EPS) in fiscal year 2025. This represents an increase of 23.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$906.4M

YoY+18.9%

5Y CAGR+8.6%

10Y CAGR+3.8%

F5 generated $906.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 18.9% from the prior year.

Cash & Debt

$1.3B

YoY+25.1%

5Y CAGR+9.6%

10Y CAGR+13.2%

F5 held $1.3B in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding

58M

YoY-0.9%

5Y CAGR-1.2%

10Y CAGR-1.9%

F5 had 58M shares outstanding in fiscal year 2025. This represents a decrease of 0.9% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

81.4%

YoY+1.2pp

5Y CAGR-1.2pp

10Y CAGR-1.3pp

F5's gross margin was 81.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.2 percentage points from the prior year.

Operating Margin

24.8%

YoY+1.4pp

5Y CAGR+8.1pp

10Y CAGR-4.0pp

F5's operating margin was 24.8% in fiscal year 2025, reflecting core business profitability. This is up 1.4 percentage points from the prior year.

Net Margin

22.4%

YoY+2.3pp

5Y CAGR+9.3pp

10Y CAGR+3.4pp

F5's net profit margin was 22.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.3 percentage points from the prior year.

Return on Equity

19.3%

YoY+1.2pp

5Y CAGR+5.5pp

10Y CAGR-8.4pp

F5's ROE was 19.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$539.8M

YoY+10.1%

5Y CAGR+4.1%

10Y CAGR+6.2%

F5 invested $539.8M in research and development in fiscal year 2025. This represents an increase of 10.1% from the prior year.

Share Buybacks

$502.1M

YoY+0.3%

5Y CAGR+38.1%

10Y CAGR-1.9%

F5 spent $502.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 0.3% from the prior year.

Capital Expenditures

$43.3M

YoY+42.2%

5Y CAGR-6.3%

10Y CAGR-3.3%

F5 invested $43.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 42.2% from the prior year.

FFIV Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

FFIV quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$3.3B	$3.1B+9.7%	$2.8B+0.1%	$2.8B+4.4%	$2.7B+3.6%	$2.6B+10.7%	$2.4B+4.8%	$2.2B+3.7%	$2.2B+3.4%	$2.1B+4.8%	$2.0B+3.9%	$1.9B+10.8%	$1.7B+16.9%	$1.5B+7.6%	$1.4B+19.6%	$1.2B
Cost of Revenue	$600.1M	$574.0M+2.9%	$557.6M-6.0%	$593.3M+9.9%	$539.6M+9.4%	$493.1M+20.9%	$407.9M+14.4%	$356.6M-1.4%	$361.5M+2.3%	$353.5M+4.8%	$337.2M+1.5%	$332.3M+7.2%	$310.0M+22.5%	$253.0M+7.1%	$236.2M+13.5%	$208.0M
Gross Profit	$2.7B	$2.5B+11.3%	$2.3B+1.7%	$2.2B+3.0%	$2.2B+2.2%	$2.1B+8.6%	$1.9B+3.0%	$1.9B+4.8%	$1.8B+3.6%	$1.7B+4.7%	$1.7B+4.4%	$1.6B+11.6%	$1.4B+15.8%	$1.2B+7.6%	$1.1B+20.9%	$943.8M
R&D Expenses	$593.3M	$539.8M+10.1%	$490.1M-9.3%	$540.3M-0.6%	$543.4M+6.0%	$512.6M+16.2%	$441.3M+8.2%	$408.1M+11.5%	$366.1M+4.5%	$350.4M+4.8%	$334.2M+12.7%	$296.6M+12.4%	$263.8M+25.8%	$209.6M+18.2%	$177.4M+27.7%	$138.9M
SG&A Expenses	$371.9M	$322.3M+19.9%	$268.8M+2.1%	$263.4M-4.1%	$274.6M+0.3%	$273.6M+5.9%	$258.4M+22.6%	$210.7M+31.4%	$160.4M+2.2%	$156.9M+13.3%	$138.4M+2.1%	$135.5M+27.3%	$106.5M+4.0%	$102.4M+11.6%	$91.8M+9.9%	$83.5M
Operating Income	$812.1M	$765.9M+16.3%	$658.6M+39.4%	$472.6M+17.0%	$403.8M+2.5%	$394.0M+0.4%	$392.3M-24.3%	$518.5M-12.3%	$590.9M+4.8%	$564.0M+3.0%	$547.4M-1.0%	$552.9M+12.0%	$493.6M+14.6%	$430.8M+1.1%	$426.3M+21.6%	$350.7M
Income Tax	$126.9M	$116.0M-9.9%	$128.7M+41.4%	$91.0M+44.0%	$63.2M+13.5%	$55.7M-37.4%	$89.0M-21.5%	$113.4M-24.5%	$150.1M-3.0%	$154.8M-15.9%	$184.0M-6.3%	$196.3M+5.5%	$186.2M+15.8%	$160.8M+2.4%	$157.0M+31.6%	$119.4M
Net Income	$726.5M	$692.4M+22.2%	$566.8M+43.5%	$394.9M+22.6%	$322.2M-2.7%	$331.2M+7.7%	$307.4M-28.1%	$427.7M-5.7%	$453.7M+7.8%	$420.8M+15.0%	$365.9M+0.2%	$365.0M+17.3%	$311.2M+12.2%	$277.3M+0.8%	$275.2M+14.0%	$241.4M
EPS (Diluted)	$12.56	$11.80+23.6%	$9.55+45.8%	$6.55+24.3%	$5.27-1.3%	$5.34+6.6%	$5.01-29.2%	$7.08-3.3%	$7.32+12.6%	$6.50+20.8%	$5.38+7.0%	$5.03+23.0%	$4.09+16.9%	$3.50+1.4%	$3.45+16.6%	$2.96

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	$865.1M+6.6%	$811.7M-1.3%	$822.5M+1.5%	$810.1M+3.8%	$780.4M+6.7%	$731.1M-4.6%	$766.5M+2.7%	$746.7M
Cost of Revenue	$153.6M+1.8%	$150.9M-0.6%	$151.8M+5.5%	$143.9M-3.2%	$148.6M+5.4%	$141.0M+0.3%	$140.5M-2.2%	$143.7M
Gross Profit	$711.5M+7.7%	$660.8M-1.5%	$670.7M+0.7%	$666.2M+5.5%	$631.7M+7.0%	$590.2M-5.7%	$626.0M+3.8%	$603.0M
R&D Expenses	$164.7M+9.0%	$151.0M+7.0%	$141.2M+3.5%	$136.4M0.0%	$136.3M-0.2%	$136.6M+4.6%	$130.5M+5.3%	$124.0M
SG&A Expenses	$95.6M+4.3%	$91.6M+1.2%	$90.6M-3.6%	$94.0M+19.5%	$78.7M+2.6%	$76.6M+5.0%	$73.0M+2.9%	$71.0M
Operating Income	$213.3M+19.1%	$179.0M-16.4%	$214.2M+4.1%	$205.7M+4.8%	$196.3M+23.5%	$158.9M-22.5%	$205.1M+7.4%	$191.0M
Income Tax	$18.0M-56.6%	$41.5M-3.3%	$42.9M+74.4%	$24.6M+6.3%	$23.1M-10.0%	$25.7M-39.7%	$42.6M+11.5%	$38.2M
Net Income	$208.2M+40.9%	$147.8M-17.9%	$180.1M-5.5%	$190.5M+0.3%	$189.9M+30.5%	$145.5M-12.6%	$166.4M+0.7%	$165.3M
EPS (Diluted)	$3.62+40.3%	$2.58-16.8%	$3.10-4.9%	$3.26+0.3%	$3.25+31.0%	$2.48-12.1%	$2.82+0.7%	$2.80

Not reported in any period shown, so not listed: Interest Expense.

FFIV Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

FFIV quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$6.3B+12.6%	$5.6B+6.9%	$5.2B-0.5%	$5.3B+5.6%	$5.0B+6.8%	$4.7B+38.0%	$3.4B+30.1%	$2.6B+5.2%	$2.5B+7.4%	$2.3B-0.3%	$2.3B+5.8%	$2.2B-2.0%	$2.2B+16.7%	$1.9B+21.8%	$1.6B
Current Assets	$2.5B+19.4%	$2.1B+14.1%	$1.8B-3.3%	$1.9B+18.7%	$1.6B-10.2%	$1.8B+18.6%	$1.5B+6.6%	$1.4B+0.8%	$1.4B+9.1%	$1.3B+8.5%	$1.2B+19.0%	$998.8M+22.4%	$816.4M+5.2%	$776.1M+1.6%	$763.7M
Cash & Equivalents	$1.3B+25.1%	$1.1B+34.8%	$797.2M+5.2%	$758.0M+30.5%	$581.0M-31.6%	$849.6M+41.8%	$599.2M+41.1%	$424.7M-36.9%	$673.2M+30.8%	$514.6M+31.8%	$390.5M+38.7%	$281.5M+48.4%	$189.7M-10.2%	$211.2M-2.6%	$216.8M
Inventory	$77.2M+1.1%	$76.4M+112.9%	$35.9M-47.5%	$68.4M+210.0%	$22.1M-20.9%	$27.9M-18.9%	$34.4M+12.5%	$30.6M+2.5%	$29.8M-12.4%	$34.1M+1.0%	$33.7M+37.8%	$24.5M+28.6%	$19.0M+9.3%	$17.4M+1.5%	$17.1M
Accounts Receivable	$414.4M+6.5%	$389.0M-14.5%	$454.8M-3.2%	$470.0M+38.0%	$340.5M+15.0%	$296.2M-8.0%	$322.0M+9.0%	$295.4M+1.2%	$291.9M+8.9%	$268.2M-4.0%	$279.4M+15.4%	$242.2M+18.6%	$204.2M+10.3%	$185.2M+11.8%	$165.7M
Goodwill	$2.4B+5.7%	$2.3B+1.0%	$2.3B+1.3%	$2.3B+1.9%	$2.2B+19.2%	$1.9B+74.5%	$1.1B+91.6%	$556.0M0.0%	$556.0M0.0%	$556.0M0.0%	$556.0M-0.2%	$557.0M+6.3%	$523.7M+50.4%	$348.2M+48.4%	$234.7M
Total Liabilities	$2.7B+9.8%	$2.5B+1.5%	$2.4B-12.8%	$2.8B+6.5%	$2.6B+7.8%	$2.4B+50.2%	$1.6B+23.4%	$1.3B+5.8%	$1.2B+11.2%	$1.1B+12.6%	$995.6M+22.1%	$815.6M+17.9%	$691.8M+18.9%	$581.8M+25.6%	$463.1M
Current Liabilities	$1.6B+8.3%	$1.5B+1.1%	$1.5B-20.0%	$1.8B+32.2%	$1.4B+8.0%	$1.3B+16.5%	$1.1B+15.8%	$954.4M+2.1%	$934.5M+10.7%	$844.2M+11.8%	$755.1M+18.5%	$637.0M+15.5%	$551.4M+18.3%	$466.0M+25.2%	$372.3M
Long-Term Debt	N/A	N/A	N/A	$0-100.0%	$349.8M-5.2%	$369.0M	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$3.6B+14.8%	$3.1B+11.8%	$2.8B+13.4%	$2.5B+4.6%	$2.4B+5.7%	$2.2B+26.7%	$1.8B+37.0%	$1.3B+4.6%	$1.2B+3.7%	$1.2B-10.0%	$1.3B-3.8%	$1.4B-11.0%	$1.5B+15.7%	$1.3B+20.3%	$1.1B
Retained Earnings	$3.6B+13.5%	$3.1B+12.3%	$2.8B+16.4%	$2.4B+9.9%	$2.2B+12.5%	$1.9B+18.8%	$1.6B+27.3%	$1.3B+4.7%	$1.2B+3.8%	$1.2B-10.3%	$1.3B-3.0%	$1.4B+6.2%	$1.3B+27.6%	$1.0B+37.6%	$731.1M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$6.8B+5.1%	$6.5B+3.3%	$6.3B-0.4%	$6.3B+3.4%	$6.1B+3.5%	$5.9B+0.1%	$5.9B+5.1%	$5.6B
Current Assets	$2.9B+9.0%	$2.7B+7.4%	$2.5B-0.1%	$2.5B+1.4%	$2.5B+6.4%	$2.3B-0.2%	$2.3B+11.0%	$2.1B
Cash & Equivalents	$1.6B+11.3%	$1.4B+20.3%	$1.2B-10.8%	$1.3B-5.8%	$1.4B+13.3%	$1.3B+9.4%	$1.2B+7.1%	$1.1B
Inventory	$126.9M+40.5%	$90.3M+13.0%	$79.9M+3.5%	$77.2M+15.4%	$66.9M-1.4%	$67.9M-7.3%	$73.2M-4.1%	$76.4M
Accounts Receivable	$428.7M+0.7%	$425.6M-13.8%	$493.6M+19.1%	$414.4M+15.2%	$359.9M-5.2%	$379.6M-21.7%	$485.0M+24.7%	$389.0M
Goodwill	$2.5B+1.6%	$2.4B0.0%	$2.4B0.0%	$2.4B+5.1%	$2.3B+0.2%	$2.3B+0.3%	$2.3B0.0%	$2.3B
Total Liabilities	$3.0B+4.4%	$2.8B+3.4%	$2.8B+1.0%	$2.7B+3.2%	$2.6B+1.9%	$2.6B-2.7%	$2.7B+7.3%	$2.5B
Current Liabilities	$1.8B+5.5%	$1.7B+3.6%	$1.6B+0.4%	$1.6B+4.0%	$1.6B+1.8%	$1.5B-4.0%	$1.6B+6.6%	$1.5B
Total Equity	$3.9B+5.6%	$3.6B+3.1%	$3.5B-1.5%	$3.6B+3.5%	$3.5B+4.8%	$3.3B+2.4%	$3.2B+3.4%	$3.1B
Retained Earnings	$3.8B+5.8%	$3.6B+1.8%	$3.6B-0.5%	$3.6B+3.4%	$3.4B+4.7%	$3.3B+1.4%	$3.3B+3.4%	$3.1B

Not reported in any period shown, so not listed: Long-Term Debt.

FFIV Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

FFIV quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$1.0B	$949.7M+19.8%	$792.4M+21.3%	$653.4M+47.6%	$442.6M-31.4%	$645.2M-2.4%	$660.9M-11.6%	$747.8M-1.7%	$761.1M+2.8%	$740.3M+4.0%	$711.5M+3.9%	$684.5M+24.7%	$549.0M+9.9%	$499.7M+0.9%	$495.4M+18.8%	$416.9M
Capital Expenditures	$79.8M	$43.3M+42.2%	$30.4M-43.9%	$54.2M+61.1%	$33.6M+9.7%	$30.7M-48.9%	$59.9M-42.1%	$103.5M+93.7%	$53.5M+38.2%	$38.7M-39.1%	$63.5M+5.3%	$60.3M+165.5%	$22.7M-14.5%	$26.6M-11.0%	$29.9M-1.9%	$30.4M
Free Cash Flow	$969.6M	$906.4M+18.9%	$762.0M+27.2%	$599.2M+46.5%	$409.0M-33.4%	$614.5M+2.3%	$601.0M-6.7%	$644.3M-8.9%	$707.6M+0.9%	$701.6M+8.3%	$648.0M+3.8%	$624.2M+18.6%	$526.3M+11.2%	$473.1M+1.6%	$465.6M+20.5%	$386.5M
Investing Cash Flow	-$278.0M	-$219.5M-270.7%	-$59.2M-262.7%	$36.4M-83.3%	$218.1M+149.0%	-$445.3M+40.4%	-$747.0M-80.2%	-$414.6M+9.1%	-$456.0M-1315.7%	-$32.2M-151.4%	$62.7M+686.2%	-$10.7M-107.1%	$150.6M+142.7%	-$352.5M-0.1%	-$352.3M-152.1%	-$139.7M
Financing Cash Flow	-$591.3M	-$464.8M-1.7%	-$457.0M+30.0%	-$653.3M-37.1%	-$476.5M-1.8%	-$468.3M-238.9%	$337.2M+317.0%	-$155.4M+71.8%	-$551.3M-1.0%	-$546.0M+16.3%	-$652.6M-17.2%	-$556.9M+7.9%	-$605.0M-263.7%	-$166.3M-11.5%	-$149.2M+34.2%	-$226.7M
Share Buybacks	N/A	$502.1M+0.3%	$500.6M+43.0%	$350.0M-30.0%	$500.0M0.0%	$500.0M+399.9%	$100.0M-50.3%	$201.0M-66.5%	$600.1M0.0%	$600.1M-14.3%	$700.1M+15.4%	$606.9M-6.7%	$650.5M+225.3%	$200.0M+8.2%	$184.8M-31.9%	$271.5M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	$316.2M-13.6%	$365.9M+129.8%	$159.2M-23.5%	$208.1M-26.3%	$282.2M+10.0%	$256.6M+26.5%	$202.8M-17.7%	$246.5M
Capital Expenditures	$35.6M+94.3%	$18.3M+88.7%	$9.7M-39.8%	$16.1M+88.9%	$8.5M-18.7%	$10.5M+30.1%	$8.1M+33.2%	$6.1M
Free Cash Flow	$280.6M-19.3%	$347.6M+132.5%	$149.5M-22.1%	$191.9M-29.9%	$273.7M+11.2%	$246.1M+26.4%	$194.7M-19.0%	$240.4M
Investing Cash Flow	-$85.0M-355.0%	-$18.7M-76.9%	-$10.6M+93.6%	-$163.8M-552.3%	-$25.1M-21.9%	-$20.6M-106.6%	-$10.0M-73.7%	-$5.7M
Financing Cash Flow	-$67.9M+34.2%	-$103.3M+64.8%	-$293.0M-130.4%	-$127.2M-36.2%	-$93.4M+27.9%	-$129.6M-13.0%	-$114.7M-12.6%	-$101.9M
Share Buybacks	$100.0M	N/A	N/A	$125.0M0.0%	$125.0M	N/A	N/A	$100.5M

Not reported in any period shown, so not listed: Dividends Paid.

FFIV Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

FFIV quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	81.4%+1.2pp	80.2%+1.3pp	78.9%-1.1pp	80.0%-1.1pp	81.1%-1.6pp	82.7%-1.4pp	84.1%+0.8pp	83.3%+0.2pp	83.1%0.0pp	83.1%+0.4pp	82.7%+0.6pp	82.1%-0.8pp	82.9%+0.1pp	82.8%+0.9pp	81.9%
Operating Margin	24.8%+1.4pp	23.4%+6.6pp	16.8%+1.8pp	15.0%-0.2pp	15.1%-1.6pp	16.7%-6.4pp	23.1%-4.2pp	27.3%+0.4pp	27.0%-0.5pp	27.4%-1.4pp	28.8%+0.3pp	28.5%-0.6pp	29.1%-1.9pp	30.9%+0.5pp	30.4%
Net Margin	22.4%+2.3pp	20.1%+6.1pp	14.0%+2.1pp	11.9%-0.8pp	12.7%-0.4pp	13.1%-6.0pp	19.1%-1.9pp	21.0%+0.9pp	20.1%+1.8pp	18.3%-0.7pp	19.0%+1.0pp	18.0%-0.8pp	18.7%-1.3pp	20.0%-1.0pp	21.0%
Return on Equity	19.3%+1.2pp	18.1%+4.0pp	14.1%+1.0pp	13.1%-1.0pp	14.0%+0.3pp	13.8%-10.5pp	24.3%-11.0pp	35.3%+1.1pp	34.2%+3.4pp	30.9%+3.1pp	27.7%+5.0pp	22.7%+4.7pp	18.0%-2.7pp	20.7%-1.1pp	21.8%
Return on Assets	11.0%+0.9pp	10.1%+2.6pp	7.5%+1.4pp	6.1%-0.5pp	6.6%+0.1pp	6.6%-6.1pp	12.6%-4.8pp	17.4%+0.4pp	17.0%+1.1pp	15.9%+0.1pp	15.8%+1.6pp	14.2%+1.8pp	12.4%-2.0pp	14.4%-1.0pp	15.4%
Current Ratio	1.56+0.1x	1.42+0.2x	1.26+0.2x	1.04-0.1x	1.16-0.2x	1.390.0x	1.37-0.1x	1.490.0x	1.500.0x	1.530.0x	1.570.0x	1.57+0.1x	1.48-0.2x	1.67-0.4x	2.05
Debt-to-Equity	0.760.0x	0.79-0.1x	0.87+0.9x	0.00-0.1x	0.150.0x	0.17+0.2x	0.00-1.0x	1.030.0x	1.01+0.1x	0.95+0.2x	0.76+0.2x	0.60+0.1x	0.450.0x	0.440.0x	0.42
FCF Margin	29.3%+2.3pp	27.1%+5.8pp	21.3%+6.1pp	15.2%-8.4pp	23.6%-1.9pp	25.6%-3.2pp	28.7%-4.0pp	32.7%-0.8pp	33.6%+1.1pp	32.5%0.0pp	32.5%+2.1pp	30.4%-1.6pp	31.9%-1.9pp	33.8%+0.3pp	33.6%

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	82.3%+0.8pp	81.4%-0.1pp	81.5%-0.7pp	82.2%+1.3pp	81.0%+0.2pp	80.7%-0.9pp	81.7%+0.9pp	80.8%
Operating Margin	24.6%+2.6pp	22.1%-4.0pp	26.0%+0.7pp	25.4%+0.2pp	25.2%+3.4pp	21.7%-5.0pp	26.8%+1.2pp	25.6%
Net Margin	24.1%+5.9pp	18.2%-3.7pp	21.9%-1.6pp	23.5%-0.8pp	24.3%+4.4pp	19.9%-1.8pp	21.7%-0.4pp	22.1%
Return on Equity	5.4%+1.3pp	4.0%-1.0pp	5.1%-0.2pp	5.3%-0.2pp	5.5%+1.1pp	4.4%-0.8pp	5.1%-0.1pp	5.3%
Return on Assets	3.0%+0.8pp	2.3%-0.6pp	2.9%-0.1pp	3.0%-0.1pp	3.1%+0.6pp	2.5%-0.4pp	2.8%-0.1pp	2.9%
Current Ratio	1.66+0.1x	1.61+0.1x	1.550.0x	1.560.0x	1.60+0.1x	1.53+0.1x	1.48+0.1x	1.42
Debt-to-Equity	0.770.0x	0.780.0x	0.780.0x	0.760.0x	0.760.0x	0.780.0x	0.820.0x	0.79
FCF Margin	32.4%-10.4pp	42.8%+24.6pp	18.2%-5.5pp	23.7%-11.4pp	35.1%+1.4pp	33.7%+8.3pp	25.4%-6.8pp	32.2%

Similar Companies

Check Point Software Tech Ltd CHKP

$14.1B

$18.6B

$36.7B

$24.0B

$18.7B

Where F5 Ranks

Frequently Asked Questions

What is F5's annual revenue?

F5 (FFIV) reported $3.1B in total revenue for fiscal year 2025. This represents a 9.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is F5's revenue growing?

F5 (FFIV) revenue grew by 9.7% year-over-year, from $2.8B to $3.1B in fiscal year 2025.

Is F5 profitable?

Yes, F5 (FFIV) reported a net income of $692.4M in fiscal year 2025, with a net profit margin of 22.4%.

What is F5's EBITDA?

F5 (FFIV) had EBITDA of $858.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is F5's gross margin?

F5 (FFIV) had a gross margin of 81.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is F5's operating margin?

F5 (FFIV) had an operating margin of 24.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is F5's net profit margin?

F5 (FFIV) had a net profit margin of 22.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is F5's return on equity (ROE)?

F5 (FFIV) has a return on equity of 19.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is F5's free cash flow?

F5 (FFIV) generated $906.4M in free cash flow during fiscal year 2025. This represents a 18.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is F5's operating cash flow?

F5 (FFIV) generated $949.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are F5's total assets?

F5 (FFIV) had $6.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are F5's capital expenditures?

F5 (FFIV) invested $43.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does F5 spend on research and development?

F5 (FFIV) invested $539.8M in research and development during fiscal year 2025.

Does F5 buy back shares?

Yes, F5 (FFIV) spent $502.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does F5 have outstanding?

F5 (FFIV) had 58M shares outstanding as of fiscal year 2025.

What is F5's current ratio?

F5 (FFIV) had a current ratio of 1.56 as of fiscal year 2025, which is generally considered healthy.

What is F5's debt-to-equity ratio?

F5 (FFIV) had a debt-to-equity ratio of 0.76 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is F5's return on assets (ROA)?

F5 (FFIV) had a return on assets of 11.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is F5's Altman Z-Score?

F5 (FFIV) has an Altman Z-Score of 6.76, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is F5's Piotroski F-Score?

F5 (FFIV) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are F5's earnings high quality?

F5 (FFIV) has an earnings quality ratio of 1.37x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is F5?

F5 (FFIV) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.